Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
QUEEN`S UNIVERSITY BELFAST has floated a tender for Contract notice: Research services. The project location is United Kingdom and the tender is closing on 16 Dec 2019. The tender notice number is 542205-2019, while the TOT Ref Number is 38069082. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : United Kingdom
Summary : Contract notice: Research services
Deadline : 16 Dec 2019
Other Information
Notice Type : Tender
TOT Ref.No.: 38069082
Document Ref. No. : 542205-2019
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Purchaser : QUEEN`S UNIVERSITY BELFAST
Office Name: Queen`s University Belfast
Address: University Road
Town: Belfast
Postal Code: BT7 1NN
Contact Point: Mrs Gillian Wasson
Phone: +44 2890973026
United Kingdom
Email :g.wasson@qub.ac.uk
URL :https://www.qub.ac.uk/directorates/FinanceDirectorate/visitors/procurement/
Tender Details
Object of the contract
Research services
Description: Contract notice: Research services
Authority Type: Body governed by public law
Contact Nature: Services
Procedure: Competitive procedure with negotiation
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: The most economic tender
CPV code: 73110000, 73110000, 85121200, 73111000, 85145000, 73110000, 85121200, 73111000, 85145000
CPV Description: Research services.
Medical specialist services.
Research laboratory services.
Services provided by medical laboratories.
QUB/1850/19 Contract for Clinical Research Organisation
Reference Number : QUB/1850/19
Queen`s University Belfast seeks to appoint a Clinical Research Organisation (CRO) to provide services in respect of conducting a multinational Phase II study in non-cystic fibrosis BE patients, sponsored by Novartis, across Europe. The trial will be jointly funded by Novartis and the EU Innovative Medicines Initiative (IMI) through the iABC consortium. IMI is Europe`s largest public-private initiative aiming to speed up the development of better and safer medicines for patients (http://www.imi.europa.eu/). Access to tender documentation is restricted to those companies who download, complete and submit a CDA to Queen`s.
Main Site : The CRO must have the capability to manage a study across multiple EU countries.
Queen`s University Belfast seeks to appoint a Clinical Research Organisation (CRO) to provide services in respect of conducting a multinational Phase II study, sponsored by Novartis, across Europe.
Economic operators seeking to obtain tender documentation, must first download, complete and submit a confidential disclosure agreement. Tender documents will not be issued until a completed CDA has been received.
Internet address (URL): https://www.qub.ac.uk/directorates/FinanceDirectorate/visitors/procurement/
Documents
Want To Bid in This Tender?
Get Local Agent Support in United Kingdom and 60 More Countries.
View Tenders By
Sign in with Google